Literature DB >> 14587278

Structural basis of matrix metalloproteinase function.

Wolfram Bode1.   

Abstract

The matrix metalloproteinases (MMPs) constitute a family of multidomain zinc endopeptidases which contain a catalytic domain with a common metzincin-like topology. The MMPs are involved not only in extracellular matrix degradation, but also in a number of other biological processes. Normally, their proteolytic activity is regulated precisely by their main endogenous protein inhibitors, in particular the tissue inhibitors of metalloproteinases (TIMPs). Disruption of this balance results in serious diseases, such as arthritis, tumour growth and metastasis, rendering the MMPs attractive targets for inhibition therapy. Knowledge of their tertiary structures is crucial for a full understanding of their functional properties. Since the first publication of atomic MMP structures in 1994, much more structural information has become available on details of the catalytic domain, on its interaction with synthetic and protein inhibitors, on domain organization and on the formation of complexes with other proteins. This review will outline our current knowledge of MMP structure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14587278     DOI: 10.1042/bss0700001

Source DB:  PubMed          Journal:  Biochem Soc Symp        ISSN: 0067-8694


  8 in total

1.  Potential of fluorescent metalloproteinase substrates for cancer detection.

Authors:  Roopali Roy; David Zurakowski; Susan Pories; Marcia L Moss; Marsha A Moses
Journal:  Clin Biochem       Date:  2011-10-06       Impact factor: 3.281

Review 2.  Zinc and gastrointestinal disease.

Authors:  Sonja Skrovanek; Katherine DiGuilio; Robert Bailey; William Huntington; Ryan Urbas; Barani Mayilvaganan; Giancarlo Mercogliano; James M Mullin
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

3.  Simple pseudo-dipeptides with a P2' glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins.

Authors:  Laurent Devel; Fabrice Beau; Mehdi Amoura; Laura Vera; Evelyne Cassar-Lajeunesse; Sandra Garcia; Bertrand Czarny; Enrico A Stura; Vincent Dive
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

4.  Immunohistochemical expression of matrix metalloproteinase-9 and inhibitor of matrix metalloproteinase-1 in prostate adenocarcinoma.

Authors:  Igor I Babichenko; Mikhail I Andriukhin; Sergey Pulbere; Artem Loktev
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

5.  Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.

Authors:  Roopali Roy; Gwendolyn Louis; Kevin R Loughlin; Dmitri Wiederschain; Susan M Kilroy; Carolyn C Lamb; David Zurakowski; Marsha A Moses
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

6.  Wound Healing Versus Regeneration: Role of the Tissue Environment in Regenerative Medicine.

Authors:  Anthony Atala; Darrell J Irvine; Marsha Moses; Sunil Shaunak
Journal:  MRS Bull       Date:  2010-08-01       Impact factor: 6.578

Review 7.  Integrative Approaches in Structural Biology: A More Complete Picture from the Combination of Individual Techniques.

Authors:  Linda Cerofolini; Marco Fragai; Enrico Ravera; Christoph A Diebolder; Ludovic Renault; Vito Calderone
Journal:  Biomolecules       Date:  2019-08-14

8.  Matrix Metalloproteinases and Bladder Cancer: What is New?

Authors:  O Rodriguez Faba; J Palou-Redorta; J M Fernández-Gómez; F Algaba; N Eiró; H Villavicencio; F J Vizoso
Journal:  ISRN Urol       Date:  2012-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.